We are live on
!
Find out more
ACM
Ativo Capital Management Portfolio holdings
AUM
$115M
1-Year Est. Return
19.02%
This Fund
S&P 500
This Quarter
Est. Return
+7.56%
1 Year Est. Return
+19.02%
3 Year Est. Return
+57.9%
5 Year Est. Return
+80.23%
10 Year Est. Return
+380.01%
AUM
$255M
AUM Growth
+$11.7M
(+4.8%)
Cap. Flow
-$2.25M
Cap. Flow
% of AUM
-0.88%
Top 10 Holdings %
Top 10 Hldgs %
28.78%
Holding
240
New
16
Increased
85
Reduced
70
Closed
50
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
WBC
WABCO HOLDINGS INC.
WBC
|
+$3.28M |
| 2 |
Aptiv
APTV
|
+$2.81M |
| 3 |
CBPO
China Biologic Products Holdings, Inc.
CBPO
|
+$2.8M |
| 4 |
Xenon Pharmaceuticals
XENE
|
+$2.54M |
| 5 |
LyondellBasell Industries
LYB
|
+$2.02M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Chubb
CB
|
+$3.79M |
| 2 |
NVO
Novo Nordisk
NVO
|
+$1.86M |
| 3 |
Royal Bank of Canada
RY
|
+$1.78M |
| 4 |
National Grid
NGG
|
+$1.75M |
| 5 |
Canadian Imperial Bank of Commerce
CM
|
+$1.68M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.88% |
| 2 | Healthcare | 21.05% |
| 3 | Financials | 9.71% |
| 4 | Consumer Discretionary | 9.24% |
| 5 | Industrials | 9.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Sensata Technologies
ST
$6.8B
| $12.1M | 4.74% |
210,620
+9,347
| +5% | +$498K |
|
2
Teva Pharmaceuticals
TEVA
$36.9B
| $11.5M | 4.5% |
184,543
+2,040
| +1% | +$119K |
|
3
TE Connectivity
TEL
$62.1B
| $8.46M | 3.31% |
118,055
-9,860
| -8% | -$677K |
|
|
TARO
4
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
| $7.88M | 3.09% |
55,873
+695
| +1% | +$107K |
|
5
SAP
SAP
$209B
| $7.31M | 2.86% |
101,239
+2,731
| +3% | +$187K |
|
|
WBC
6
DELISTED
WABCO HOLDINGS INC.
WBC
| $5.95M | 2.33% |
48,449
+30,210
| +166% | +$3.28M |
|
|
CBPO
7
DELISTED
China Biologic Products Holdings, Inc.
CBPO
| $5.71M | 2.24% |
59,789
+37,490
| +168% | +$2.8M |
|
8
Pentair
PNR
$10.8B
| $5.11M | 2% |
120,928
-28,693
| -19% | -$1.25M |
|
|
9
Aptiv
APTV
$12.6B
| $5.09M | 1.99% |
63,802
+37,393
| +142% | +$2.81M |
|
10
Accenture
ACN
$101B
| $4.42M | 1.73% |
47,145
+1,677
| +4% | +$150K |
|
11
CGI
GIB
$15B
| $4.15M | 1.62% |
97,718
+2,023
| +2% | +$82.8K |
|
12
Brookfield
BN
$104B
| $4.14M | 1.62% |
330,031
+21,429
| +7% | +$266K |
|
13
Amdocs
DOX
$5.83B
| $4.01M | 1.57% |
73,769
+33,877
| +85% | +$1.71M |
|
|
14
LyondellBasell Industries
LYB
$18.8B
| $3.57M | 1.4% |
40,663
+23,963
| +143% | +$2.02M |
|
15
TSMC
TSM
$2.03T
| $2.88M | 1.13% |
122,546
-5,777
| -5% | -$136K |
|
16
AerCap
AER
$24.3B
| $2.72M | 1.07% |
62,336
+4,900
| +9% | +$207K |
|
17
Toyota
TM
$221B
| $2.54M | 1% |
18,174
-213
| -1% | -$28.4K |
|
18
Simon Property Group
SPG
$76.8B
| $2.54M | 0.99% |
12,969
+1,675
| +15% | +$325K |
|
19
UnitedHealth
UNH
$389B
| $2.47M | 0.97% |
20,898
+2,416
| +13% | +$268K |
|
20
AB InBev
BUD
$161B
| $2.43M | 0.95% |
19,951
-466
| -2% | -$56.3K |
|
21
Omnicom Group
OMC
$24.6B
| $2.41M | 0.94% |
30,906
+4,874
| +19% | +$372K |
|
22
Roper Technologies
ROP
$38.7B
| $2.39M | 0.94% |
13,920
+4,134
| +42% | +$669K |
|
23
Novartis
NVS
$304B
| $2.38M | 0.93% |
26,900
-694
| -3% | -$61.6K |
|
|
TTM
24
DELISTED
Tata Motors Limited
TTM
| $2.35M | 0.92% |
52,057
+273
| +0.5% | +$12.9K |
|
|
FISV
25
Fiserv Inc
FISV
$28.9B
| $2.32M | 0.91% |
58,398
+7,632
| +15% | +$291K |
|
Similar funds
IASG
PCM
CF
B
ACM
PHWM
RA
MCI
Ativo Capital Management's Q1 2015 Portfolio in Review
As of Q1 2015, Ativo Capital Management held 240 positions worth $255M, up 4.8% from $244M the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Ativo Capital Management's Q1 2015 filing shows 16 new, 85 increased, 70 reduced and 50 closed positions. Its largest new stake was Xenon Pharmaceuticals: 137,389 shares worth $2.32M. The largest sale was Chubb, an estimated $3.79M.
By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 26% a quarter earlier, followed by Healthcare and Financials.
- Ativo Capital Management's largest Q1 2015 buy was Xenon Pharmaceuticals: 137,389 shares worth $2.32M.
- Ativo Capital Management added most to WABCO HOLDINGS INC. in Q1 2015, an estimated $3.28M increase.
- Ativo Capital Management's biggest Q1 2015 reduction was Novo Nordisk, cutting an estimated $1.86M.
- Ativo Capital Management fully exited Chubb in Q1 2015, selling an estimated $3.79M.
- Ativo Capital Management's ten largest holdings make up 29% of its $255M portfolio in Q1 2015.
- Ativo Capital Management opened 16 new positions and closed 50 in Q1 2015.
- Ativo Capital Management's portfolio value rose 4.8% quarter-over-quarter to $255M.
Based on Ativo Capital Management's 13F filing for Q1 2015, filed 15 May 2015.